Rapid Micro Biosystems Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.7% | +1.5% | +2.7% | +3.7% | +1.2% | -2.5% | -4.3% | -0.9% | -1.7% | -10.6% | -4.5% | – | |
| – | -18.3% | +6.2% | +7.9% | -20.7% | -25.8% | +51.2% | +16.9% | -5.9% | -45.3% | +95.1% | +8.0% | – | |
| – | -96.0% | -5,352.6% | – | +46.4% | -369.5% | – | – | – | – | -146.8% | – | – | |
| – | -7.7% | +40.0% | -21.5% | -51.4% | -56.1% | +225.5% | +14.7% | -80.1% | +26.0% | +328.3% | -43.4% | – | |
| – | +110.0% | +35.0% | +83.6% | -126.3% | – | +119.6% | -12.5% | -202.6% | – | +121.1% | -50.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -33.3% | +16.7% | +0.0% | – | -100.0% | +12.5% | +0.0% | – | |
| – | -125.0% | – | -106.3% | – | -109.8% | – | -178.6% | – | -97.7% | -44.2% | +3,686.6% | – | |
| – | – | -471.1% | – | -202.6% | – | – | -128.7% | – | +76.8% | -673.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.